/
/
/

Syncom Formulations (India) Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)20.93
Volume (₹)72.31 L
High (₹)21.88
Upper Circuit25.63
Low (₹)20.50
Lower Circuit17.09
Prev Close21.36
52W High (₹)22.59
Price20.65
52W Low (₹)10.21

Share Market Cap & Key Ratios Overview

M.Cap (₹)2002.20 Cr
Div. Yield (%)0.00
PE Ratio23.41
Debt to Equity0.01
Price to Book4.52
Book Value3.64
EPS (TTM)0.91
Face Value1.00
ROE (%)15.69

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
SYNCOMFNSE
LTP
1W Low
1W High
Market cap (₹)
1904.7-15.3 (-0.80%)
1902
1984.80
4,56,833Cr
9188.5-50.5 (-0.55%)
9087
9467
2,45,426Cr
4902-148 (-2.93%)
4886.50
5066
1,87,320Cr
1133.6-57.4 (-4.82%)
1125.10
1187
1,13,217Cr
1390.3-33.2 (-2.33%)
1376.70
1426.10
1,12,212Cr
1853.1-85.4 (-4.41%)
1811.70
1949
1,01,155Cr
2126.4-45.1 (-2.08%)
2118.10
2192
97,626Cr
2351.8-31.1 (-1.31%)
2341.20
2419.20
96,859Cr
1164.5-13.5 (-1.15%)
1154.40
1179.90
96,406Cr
1654.7+9.4 (0.57%)
1622.60
1717
93,614Cr
20.65+1.19 (6.12%)
18.76
22.59
2,002Cr

Key Highlights of Syncom Formulations (India) Ltd Balance Sheet

Syncom Formulations (India) Ltd balance sheet discloses shareholders' funds of ₹94Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹94Cr, and the reserves and surplus of the company is ₹245.9Cr.

The company has its non-current liabilities with total liabilities of ₹412.1Cr as of 2025-03-31.

The current liabilities are ₹60.38Cr as of 2025-03-31. At the same time, current assets are ₹269.88Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹3.65Cr and tangible assets of ₹77.57Cr, provided in the Syncom Formulations (India) Ltd financial statements.